cyclopentane has been researched along with Schizophrenia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cieślik, P; Kalinowski, L; Kusek, M; Pelikant-Małecka, I; Pilc, A; Płoska, A; Radulska, A; Sławiński, J; Tokarski, K; Wierońska, JM; Woźniak, M; Żołnowska, B | 1 |
| Acher, F; Gruca, P; Lasoń-Tyburkiewicz, M; Marciniak, M; Papp, M; Pilc, A; Wierońska, JM; Woźniak, M | 1 |
| Lawrence, AJ | 1 |
| Auclair, AL; Bardin, L; Colpaert, F; Depoortère, R; Kleven, MS; Newman-Tancredi, A; Prinssen, E; Vacher, B | 1 |
4 other study(ies) available for cyclopentane and Schizophrenia
| Article | Year |
|---|---|
Simultaneous activation of muscarinic and GABA
Topics: Allosteric Regulation; Animals; Antipsychotic Agents; Benzamides; Brain; Cyclopentanes; Disease Models, Animal; Drug Therapy, Combination; Excitatory Postsynaptic Potentials; Indoles; Male; Mice; Neurotransmitter Agents; Pyridines; Pyrimidines; Receptors, GABA-B; Receptors, Muscarinic; Schizophrenia; Thiophenes | 2019 |
Involvement of GABAB Receptor Signaling in Antipsychotic-like Action of the Novel Orthosteric Agonist of the mGlu4 Receptor, LSP4-2022.
Topics: Amphetamine; Animals; Antipsychotic Agents; Cyclopentanes; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Excitatory Amino Acid Agonists; GABA Agents; Male; Mice, Knockout; Motor Activity; Phosphinic Acids; Pyrimidines; Receptors, GABA-B; Receptors, Metabotropic Glutamate; Recognition, Psychology; Schizophrenia; Social Behavior | 2016 |
Optimisation of anti-psychotic therapeutics: a balancing act?
Topics: Antipsychotic Agents; Benzofurans; Benzylamines; Cyclopentanes; Dopamine D2 Receptor Antagonists; Humans; Schizophrenia; Serotonin 5-HT1 Receptor Agonists | 2007 |
F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophrenia.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Benzofurans; Benzylamines; Cyclopentanes; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Male; Mice; Mice, Inbred Strains; Models, Animal; Motor Activity; Piperazines; Prolactin; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D3; Receptors, Dopamine D4; Reflex, Startle; Schizophrenia; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists; Treatment Outcome | 2007 |